Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND1 | P24385 | 16/20 | 0.76 |
| ▸ | CDK6 | Q00534 | 13/20 | 0.76 |
| ▸ | CDK4 | P11802 | 10/20 | 0.61 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.48 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | CCND3 | P30281 | 1/20 | 0.48 |
| ▸ | CDK9 | P50750 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25234317 | 1.00 | CCND1 (0.76) | CCND1CDK6CDK4CCNT1CCNA2 | |
| SCHEMBL25282128 | 0.86 | CCND1 (1.00) | CCND1CDK6CDK4 | |
| SCHEMBL29514757 | 0.86 | CCND1 (1.00) | CCND1CDK6CDK4 | |
| SCHEMBL17489242 | 0.80 | CDK6 (0.65) | CCND1CDK6CDK4CCNT1CCNA2 | |
| SCHEMBL25237805 | 0.79 | CCND1 (1.00) | CCND1CDK6CDK4CCNT1CCNA2 | |
| SCHEMBL29514845 | 0.79 | CCND1 (1.00) | CCND1CDK6CDK4CCNT1CCNA2 | |
| SCHEMBL24322174 | 0.79 | CCND1 (0.72) | CCND1CDK6CDK4CCNA2CDK2 | |
| SCHEMBL25695256 | 0.79 | CCND1 (0.80) | CCND1CDK6CDK4CCNA2CDK2 | |
| SCHEMBL17488844 | 0.79 | CDK6 (0.66) | CCND1CDK6CDK4CCNT1CCNA2 | |
| SCHEMBL17488843 | 0.79 | CDK6 (0.66) | CCND1CDK6CDK4CCNT1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4214213-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2023-07-26 | — | — | EP | claimed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | claimed |
| EP-4214213-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | disclosed |